A Synthetic Biology Approach for Vaccine Candidate Design against Delta Strain of SARS-CoV-2 Revealed Disruption of Favored Codon Pair as a Better Strategy over Using Rare Codons
The SARS-CoV-2 delta variant (B.1.617.2) appeared for the first time in December 2020 and later spread worldwide. Currently available vaccines are not so efficacious in curbing the viral pathogenesis of the delta strain of COVID; therefore, the development of a safe and effective vaccine is required...
שמור ב:
| Главные авторы: | , |
|---|---|
| פורמט: | Статья |
| שפה: | English |
| יצא לאור: |
2023
|
| נושאים: | |
| גישה מקוונת: | https://dspace.ncfu.ru/handle/20.500.12258/23532 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|